
A 2026 evidence matrix for FDA digitally derived measures, covering endpoint roles, verification, validation, missingness, change control, and a stride-length example.
IntuitionLabs is now a member of the Claude Partner Network – AI training and upskilling with Claude for pharma and biotech. Book a call.

A 2026 evidence matrix for FDA digitally derived measures, covering endpoint roles, verification, validation, missingness, change control, and a stride-length example.

A 2026 implementation crosswalk for ICH E6(R3) Annex 2, covering the 15 January 2027 EU date, remote consent, DHT and EHR controls, RWD fitness, and control ownership.

Analyze the FDA CDER 2026 guidance pipeline for artificial intelligence in drug manufacturing and digital health technologies in pharmaceutical development.

A comprehensive guide to decentralized clinical trials (DCTs). Review hybrid trial technologies, compare software platforms, and explore implementation steps.
© 2026 IntuitionLabs. All rights reserved.